Kawano Y, Mizuta K, Sanada Y, Urahashi T, Ihara Y, Okada N, Yamada N, Sasanuma H, Sakuma Y, Taniai N, Yoshida H, Kawarasaki H, Yasuda Y, Uchida E
Department of Surgery, Nippon Medical School, Tokyo, Japan.
Department of Transplant Surgery, Jichi Medical University, Tochigi, Japan.
Transplant Proc. 2016 May;48(4):1156-61. doi: 10.1016/j.transproceed.2015.12.114.
Although hepatic vein stenosis after liver transplantation is a rare complication, the complication rate of 1% to 6% is higher in pediatric living-donor liver transplantation than that in other liver transplantation cases. Diagnosis is very important because this complication can cause hepatic congestion that develops to liver cirrhosis, graft loss, and patient loss. However, this is unlikely in cases where there are no ascites or hypoalbuminemia.
Eleven of 167 patients who had undergone pediatric living-donor liver transplantation were identified in the outpatient clinic at Jichi Medical University as having suffered from hepatic vein stenosis, and were enrolled in the study.
We conducted a retrospective study in which we reviewed historical patient records to investigate the parameters for diagnosis and examine treatment methods and outcomes.
The 11 patients were treated with 16 episodes of balloon dilatation. Three among these received retransplantation and another 2 cases required the placement of a metallic stent at the stenosis. Histological examination revealed severe fibrosis in four of nine patients who had a liver biopsy, with mild fibrosis revealed in the other five grafts. Furthermore, hepatomegaly and splenomegaly diagnosed by computed tomography, elevated levels of hyarulonic acid, and/or a decrease in calcineurin inhibitor clearance were found to be pathognomonic at diagnosis, and tended to improve after treatment.
Diagnosis of hepatic vein stenosis after liver transplantation can be difficult, so careful observation is crucial to avoid the risk of acute liver dysfunction. Comprehensive assessment using volumetry of the liver and spleen and monitoring of hyarulonic acid levels and/or calcineurin inhibitor clearance, in addition to some form of imaging examination, is important for diagnosis and evaluation of the effectiveness of therapy.
尽管肝移植后肝静脉狭窄是一种罕见的并发症,但小儿活体肝移植中1%至6%的并发症发生率高于其他肝移植病例。诊断非常重要,因为这种并发症可导致肝充血,进而发展为肝硬化、移植肝丢失和患者死亡。然而,在没有腹水或低白蛋白血症的情况下,这种情况不太可能发生。
在秩父医科大学门诊诊所,167例接受小儿活体肝移植的患者中有11例被确诊为肝静脉狭窄,并纳入本研究。
我们进行了一项回顾性研究,回顾患者的历史记录,以调查诊断参数,并检查治疗方法和结果。
11例患者接受了16次球囊扩张治疗。其中3例接受了再次移植,另外2例在狭窄处需要放置金属支架。组织学检查显示,9例接受肝活检的患者中有4例出现严重纤维化,另外5例移植肝显示轻度纤维化。此外,通过计算机断层扫描诊断的肝肿大和脾肿大、透明质酸水平升高和/或钙调神经磷酸酶抑制剂清除率降低在诊断时具有特征性,治疗后往往有所改善。
肝移植后肝静脉狭窄的诊断可能很困难,因此仔细观察对于避免急性肝功能障碍的风险至关重要。除了某种形式的影像学检查外,使用肝脏和脾脏容积测量以及监测透明质酸水平和/或钙调神经磷酸酶抑制剂清除率进行综合评估,对于诊断和评估治疗效果很重要。